Pharmaceutical Product Development Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 226.7 | 187.4 | 190.9 |
| Net Investing Cash Flow | (171.9) | (265.7) | (129.2) |
| Net Financing Cash Flow | (64.9) | 71.8 | (16.2) |
| Net Change in Cash | (8.4) | (2.2) | 37.7 |
| Depreciation & Amortization | 55.6 | 47.7 | 40.3 |
| Capital Expenditures | (94.9) | (148.1) | (109.9) |
| Cash Dividends Paid | (22.6) | (12.3) | (60.7) |





